Anil Raghani

Anil Raghani has over two decades of experience in the pharmaceutical industry. Anil currently serves as the Director of Analytical Chemistry, QC/CMC Development at Fulcrum Therapeutics since April 2021. Prior to that, they worked at Coherus BioSciences as the Director of CMC Strategy from November 2016 to June 2017. Anil also served as an Analytical CMC Consultant during the same period. Before joining Coherus BioSciences, Anil worked at AMGEN for over a decade, where they held the position of Team Leader/Principal Scientist in Analytical Sciences from August 2003 to October 2014. Anil started their career at Pfizer (formerly G.D. Searle & Co./Pharmacia) in June 1997 as a Principal Research Scientist in Analytical Development, where they worked until July 2003.

Anil Raghani received a Ph.D. in Analytical Chemistry from the University of Florida.